Immunome Inc. IMNM
- IM-3050 — Solid Tumors Phase 1
FAP (4 companies · 4 programs)
Companies with an active program directed at FAP.
MiNK Therapeutics, Inc. INKT
- MiNK-215 — Colorectal Cancer Preclinical
RECURSION PHARMACEUTICALS, INC. RXRX
- REC-4881 — Familial Adenomatous Polyposis Phase 2
Telix Pharmaceuticals Ltd TLX
- TLX400-Tx Preclinical